In its very early phases, COVID-19 shifts the associations between alcohol consumption and psychological symptoms in young adults
These findings suggest a shift in the association between psychological symptoms and alcohol use following COVID-19, as well as a differential impact of psychological symptoms, depending on their changes related to the pandemic. Changes in anxiety may contribute to riskier alcohol use behaviors following the pandemic, while depression appears to be one of the most critical factors influencing alcohol use during such crisis situations.
Authors
- Andreas Heinz (ORCID: https://orcid.org/0000-0001-5405-9065)
- Sylvane Desrivières (ORCID: https://orcid.org/0000-0002-9120-7060)
- Karina Jansone (ORCID: https://orcid.org/0000-0002-0902-0628)
- Tomáš Paus (ORCID: https://orcid.org/0000-0003-1495-9338)
- Tobias Banaschewski (ORCID: https://orcid.org/0000-0003-4595-1144)
- Emanuel Schwarz (ORCID: https://orcid.org/0000-0002-0261-5063)
- Marie‐Laure Paillère Martinot (ORCID: https://orcid.org/0000-0002-0452-2450)
- Arun L.W. Bokde (ORCID: https://orcid.org/0000-0003-0114-4914)
- Nathalie Holz (ORCID: https://orcid.org/0000-0002-6225-9267)
- Antoine Grigis (ORCID: https://orcid.org/0000-0001-7984-3710)
- Henrik Walter (ORCID: https://orcid.org/0000-0002-9403-6121)
- Luise Poustka (ORCID: https://orcid.org/0000-0002-7738-4394)
- Michael N. Smolka (ORCID: https://orcid.org/0000-0001-5398-5569)
- Dimitri Papadopoulos Orfanos (ORCID: https://orcid.org/0000-0002-1242-8990)
- Olaf Reis (ORCID: https://orcid.org/0000-0001-6480-6431)
- Frauke Nees (ORCID: https://orcid.org/0000-0002-7796-8234)
- Penny Anne Gowland (ORCID: https://orcid.org/0000-0002-4900-4817)
- Eric Artiges A (ORCID: https://orcid.org/0000-0003-4461-7646)
- Günter Schumann (ORCID: https://orcid.org/0000-0002-7740-6469)
- Hugh Garavan
- Robert Whelan
- Jean-Luc Martinot
- Herta Flor
- Nilakshi Vaidya (ORCID: https://orcid.org/0000-0002-4600-7158)
Institutions
- University of Vermont (US)
- Centre National de la Recherche Scientifique (FR)
- University of Nottingham (GB)
- Inserm (FR)
- University of Mannheim (DE)
- King's College London (GB)
- University of Toronto (CA)
- Trinity College Dublin (IE)
- Heidelberg University (DE)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- University Hospital Heidelberg (DE)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Christian-Albrechts-Universität zu Kiel (DE)
- Humboldt-Universität zu Berlin (DE)
- Sorbonne Université (FR)
- German Center for Pediatric and Adolescent Rheumatology (DE)
- Central Institute of Mental Health (DE)
- Pitié-Salpêtrière Hospital (FR)
- CEA Paris-Saclay (FR)
- Laboratoire de Biologie et Pharmacologie Appliquée (FR)
- German Center for Diabetes Research (DE)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
- University of Rostock (DE)
- Université de Montréal (CA)
- Freie Universität Berlin (DE)
- Technische Universität Dresden (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- European Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1192/j.eurpsy.2025.2450
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Fondation de l'Avenir pour la Recherche Médicale Appliquée
- Government of the United Kingdom
- UK Research and Innovation
- University of Oxford
- European Commission
- Science Foundation Ireland
- Deutsche Forschungsgemeinschaft
- Universität Heidelberg
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- National Natural Science Foundation of China
- Bundesministerium für Bildung und Forschung
- Fondation pour la Recherche Médicale
- Fondation de France
- Fédération pour la Recherche sur le Cerveau
- Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives
- H. Lundbeck A/S
- National Institutes of Health
- HORIZON EUROPE Framework Programme
- Medical Research Council